Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for Prevention of Contrast-Induced Nephropathy (PROMISS)
NCT00259441Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of simvastatin in contrast-induced nephropathy (CIN), sponsored by Seoul National University Hospital. Started Feb 2005; status: completed.
02
Drugs
simvastatin
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00259441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259441.